Cybin (HELP) Total Debt (2021)

Cybin's (HELP) quarterly Total Debt came in at $2.4 million in Q4 2021, up 730.83% on a QoQ basis from $288370.6 in Q3 2021.

Cybin (HELP) Total Debt (2021) Analysis & Trends

Cybin (HELP) has 1 years of Total Debt data on file, last reported at $2.4 million in Q4 2021.

Quarterly Total Debt changed N/A year-over-year to $2.4 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $2.4 million (changed N/A YoY) and the FY2021 annual result came in at $828319.0, changed N/A from the prior year.
Total Debt grew to $2.4 million in Q4 2021, from $288370.6 in the prior quarter.
In the past five years, Total Debt ranged from a high of $2.4 million in Q4 2021 to a low of $288370.6 in Q3 2021.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	1.99 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	1.07 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	9.34 Bn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	546.77 Mn
10	Cybin	417.29 Mn	417.29 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2021	2.40 Mn
Sep 30, 2021	288,370.58
Jun 30, 2021	626,415.91
Mar 31, 2021	864,368.44